share_log

Canaccord Genuity Maintains Buy on Quipt Home Medical, Lowers Price Target to $8

Benzinga ·  May 17 22:43

Canaccord Genuity analyst Richard Close maintains Quipt Home Medical (NASDAQ:QIPT) with a Buy and lowers the price target from $9 to $8.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment